Nicorette Invisipatch (Nicotine)

Nicotine, the active ingredient in Nicorette Invisipatch, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. It helps adult smokers who want to quit by delivering a steady dose of nicotine to reduce withdrawal symptoms and cravings.

GNH USA supplies Nicorette Invisipatch as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product is manufactured for the European Union market and meets EU pharmacovigilance and quality requirements. It is distributed under strict Good Distribution Practice to ensure product integrity during transport and storage.

Nicorette Invisipatch, a nicotine replacement therapy, is used in the management of nicotine dependence during smoking cessation programs. - Smoking cessation: provides controlled nicotine delivery to lessen withdrawal symptoms and support quitting. - Tobacco dependence: assists individuals who are regularly using tobacco products to reduce cravings during a quit attempt. - Relapse prevention: helps maintain abstinence after initial cessation by stabilizing nicotine levels. - Adjunct to counseling: used together with behavioral support programs to improve quit rates. - Nicotine withdrawal management: alleviates symptoms such as irritability, anxiety, and difficulty concentrating during cessation.

The most frequently reported reactions to transdermal nicotine patches involve the application site and mild systemic symptoms.

Common Side Effects: - Skin irritation: redness, itching, or mild rash at the patch site. - Sleep disturbance: difficulty falling asleep or staying asleep. - Vivid dreams: unusually intense or memorable dreams. - Nausea: mild stomach upset or queasiness.

Serious or Rare Side Effects: - Allergic reaction: swelling, hives, or difficulty breathing. - Severe skin reaction: blistering or extensive dermatitis. - Cardiovascular events: chest pain, palpitations, or hypertension. - Dizziness or fainting: sudden light‑headedness or loss of consciousness. - Severe headache: persistent, throbbing pain not relieved by usual measures.

When using Nicorette Invisipatch, certain precautions help ensure safe and effective therapy. - Assess nicotine dependence: evaluate the smoker’s level of addiction before initiating therapy. - Follow prescribing guidance: use the patch strength recommended by a healthcare professional. - Avoid concurrent nicotine products: do not use cigarettes, e‑cigarettes, or other nicotine replacement therapies while wearing the patch. - Keep away from children: store patches out of reach to prevent accidental exposure. - Monitor cardiovascular status: individuals with heart disease should use the patch under medical supervision. - Store at room temperature: keep in the original packaging, protect from moisture and direct heat.

Nicotine patches can interact with other medicines, affecting nicotine levels or cardiovascular responses.

Major Interactions (Avoid): - Use with other nicotine replacement products: may cause nicotine overdose and increased side‑effects. - Monoamine oxidase inhibitors (MAOIs): combined use can elevate blood pressure and cause hypertensive crises.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., methoxsalen): may slow nicotine metabolism, raising plasma nicotine. - Beta‑blockers: nicotine‑induced tachycardia may be masked, requiring careful monitoring. - Certain antidepressants (e.g., bupropion): can increase insomnia or nervousness when combined with nicotine. - Antihypertensive drugs: nicotine may reduce their effectiveness, necessitating dose adjustment.